Insulin analogues in children with Type 1 diabetes: a 52-week randomized clinical trial

Aims This 52-week, randomized, multinational, open-label, parallel-group, non-inferiority trial investigated the efficacy and safety of basal–bolus treatment with insulin detemir vs. NPH (neutral protamine Hagedorn) insulin, in combination with insulin aspart, in subjects aged 2–16 years with Type 1...

Descripción completa

Detalles Bibliográficos
Autores principales: Thalange, N, Bereket, A, Larsen, J, Hiort, L C, Peterkova, V
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2013
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3579233/
https://www.ncbi.nlm.nih.gov/pubmed/23094597
http://dx.doi.org/10.1111/dme.12041

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3579233/
https://www.ncbi.nlm.nih.gov/pubmed/23094597
http://dx.doi.org/10.1111/dme.12041

Ejemplares similares